These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22350012)

  • 1. Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition.
    Yu SJ; Yoon JH; Yang JI; Cho EJ; Kwak MS; Jang ES; Lee JH; Kim YJ; Lee HS; Kim CY
    J Bioenerg Biomembr; 2012 Feb; 44(1):101-15. PubMed ID: 22350012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.
    Kim W; Yoon JH; Jeong JM; Cheon GJ; Lee TS; Yang JI; Park SC; Lee HS
    Mol Cancer Ther; 2007 Sep; 6(9):2554-62. PubMed ID: 17876052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.
    Yu SJ; Yoon JH; Lee JH; Myung SJ; Jang ES; Kwak MS; Cho EJ; Jang JJ; Kim YJ; Lee HS
    Acta Pharmacol Sin; 2011 Jul; 32(7):912-20. PubMed ID: 21666701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
    Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.
    Yoo JJ; Yu SJ; Na J; Kim K; Cho YY; Lee YB; Cho EJ; Lee JH; Kim YJ; Youn H; Yoon JH
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress.
    Lovat PE; Corazzari M; Armstrong JL; Martin S; Pagliarini V; Hill D; Brown AM; Piacentini M; Birch-Machin MA; Redfern CP
    Cancer Res; 2008 Jul; 68(13):5363-9. PubMed ID: 18593938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model.
    Cho EJ; Yu SJ; Kim K; Cho H; Cho YY; Lee YB; Lee JH; Kim YJ; Youn H; Yoon JH
    J Bioenerg Biomembr; 2019 Apr; 51(2):121-129. PubMed ID: 30746618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein disulfide isomerase modification and inhibition contribute to ER stress and apoptosis induced by oxidized low density lipoproteins.
    Muller C; Bandemer J; Vindis C; Camaré C; Mucher E; Guéraud F; Larroque-Cardoso P; Bernis C; Auge N; Salvayre R; Negre-Salvayre A
    Antioxid Redox Signal; 2013 Mar; 18(7):731-42. PubMed ID: 23083489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model.
    Kwak MS; Yu SJ; Yoon JH; Lee SH; Lee SM; Lee JH; Kim YJ; Lee HS; Kim CY
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2037-45. PubMed ID: 25989942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma.
    Vatolin S; Phillips JG; Jha BK; Govindgari S; Hu J; Grabowski D; Parker Y; Lindner DJ; Zhong F; Distelhorst CW; Smith MR; Cotta C; Xu Y; Chilakala S; Kuang RR; Tall S; Reu FJ
    Cancer Res; 2016 Jun; 76(11):3340-50. PubMed ID: 27197150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of protein disulfide isomerase in subtilase cytotoxin-induced cell death in HeLa cells.
    Tsutsuki H; Zhang T; Harada A; Rahman A; Ono K; Yahiro K; Niidome T; Sawa T
    Biochem Biophys Res Commun; 2020 May; 525(4):1068-1073. PubMed ID: 32184018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of hepatocellular carcinoma cells to suppression of hepatocystin transcription under hypoxic conditions.
    Yoo JJ; Lee DH; Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    J Bioenerg Biomembr; 2016 Dec; 48(6):581-590. PubMed ID: 27640193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
    Won JK; Yu SJ; Hwang CY; Cho SH; Park SM; Kim K; Choi WM; Cho H; Cho EJ; Lee JH; Lee KB; Kim YJ; Suh KS; Jang JJ; Kim CY; Yoon JH; Cho KH
    Hepatology; 2017 Sep; 66(3):855-868. PubMed ID: 28439950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacitracin is not a specific inhibitor of protein disulfide isomerase.
    Karala AR; Ruddock LW
    FEBS J; 2010 Jun; 277(11):2454-62. PubMed ID: 20477872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy.
    Zhang G; Wang Z; Chen W; Cao Y; Wu J; Qiang G; Ji A; Wu J; Jiang C
    Int J Biochem Cell Biol; 2019 Aug; 113():48-57. PubMed ID: 31128260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.
    Rai Y; Yadav P; Kumari N; Kalra N; Bhatt AN
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31506393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
    Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
    J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits proliferation and apoptosis of vascular smooth muscle cells induced by mechanical stretch via the PDI/ERS and MAPK pathways.
    Wang L; Deng L; Lin N; Shi Y; Chen J; Zhou Y; Chen D; Liu S; Li C
    Life Sci; 2020 Oct; 259():118253. PubMed ID: 32795536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress.
    Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y
    Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression.
    Gwak GY; Yoon JH; Kim KM; Lee HS; Chung JW; Gores GJ
    J Hepatol; 2005 Mar; 42(3):358-64. PubMed ID: 15710218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.